Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: Implications for reactive oxygen species

Abstract

Abstract:Type 2 diabetes mellitus is associated with clustering of cardiovascular risk factors that may greatly increase individuals' risk of developing coronary artery disease. Type 2 diabetes is believed to impair coronary function. However, its impact on the vasomotor function of coronary resistance vessels in humans is still debated. Reduced, preserved or even augmented dilations of coronary arterioles have been reported in subjects with type 2 diabetes. Interestingly, recent studies have suggested that reactive oxygen species (ROS), particularly hydrogen peroxide, may compensate for the loss of the vasodilatory function of coronary microvessels during disease development. Recent interventional clinical trials have yielded largely negative results, and there has even been some suggestion of harm caused by attempts to reduce ROS. Thus, it is possible that interference with ROS-related signaling might paradoxically temper the function of coronary microvessels, predisposing patients to myocardial ischemia. In this review, we aim to highlight current findings supporting a potential role for ROS in preserving coronary arteriolar dilation in type 2 diabetes mellitus.

Cross Talk Between Ceramide and Redox Signaling: Implications for Endothelial Dysfunction and Renal Disease

“…Abnormal redox signaling is frequently involved in various pathophysiological processes such as senescence (Colavitti and Finkel 2005), inflammation (Azad et al 2008; Muller-Peddinghaus 1989; Yamamoto et al 2009), hypoxia (Bell and Chandel 2007; Guzy and Schumacker 2006; Kietzmann and Gorlach 2005; MacFarlane et al 2008), and ischemia/reperfusion (Goswami et al 2007; Szocs 2004; Toledo-Pereyra et al 2004), which contribute to the progression of almost all diseases, from cardiovascular ones such as shock (Flowers and Zimmerman 1998; Gendzwill 2007a, b), hypertension (Delles et al 2008; Hirooka 2008; Ong et al 2008; Paravicini and Touyz 2008; Puddu et al 2008; Zeng et al 2009), and atherosclerosis (Kojda and Harrison 1999; Patel et al 2000), to metabolic ones such as diabetes mellitus (Bagi et al 2009; Ksiazek and Wisniewska 2001), to neurodegenerative ones such as Alzheimer's disease (Casadesus et al 2004; Perry et al 1998), infectious diseases (Jamaluddin et al 2009; Mashimo et al 2006; Ochsendorf 1998; Sun et al 2008), and cancer (Azad et al 2009; Oyagbemi et al 2009; Weinberg and Chandel 2009). Currently, it is of high interest to explore how redox signaling is regulated under both physiological and pathological conditions.…”

Lipid Raft Redox Signaling: Molecular Mechanisms in Health and Disease

“…Introduction R edox signaling is increasingly regarded as an important cellular process in a variety of cellular activities, including cell proliferation (50,52,275), differentiation (72,153,219,337,338), and apoptosis (162,242,254,304,413). Redox injury, as a pathological mechanism, is also involved in a wide range of pathophysiological processes such as senescence (65), inflammation (17,264,421), hypoxia (32,148,200,245), and ischemia/reperfusion (126,379,384), which contribute to the progression of almost all diseases, from cardiovascular ones such as shock (94,116,117), hypertension (73,167,288,294,316,440), atherosclerosis (208,297), to metabolic ones such as diabetes mellitus (20,217), neurodegenerative ones such as Alzheimer's disease (AD) (55,305), infectious diseases (184,252,285,375), and cancer (16,…”

Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders

“…Redox injury, as a pathological mechanism, is involved in a widerangeofpathophysiologicalprocesses,including senescence, inflammation, hypoxia and ischemia/ reperfusion 19,20) , all of which may contribute to the progression of various diseases, from cardiovascular disorders, such as hypertension 21) and atherosclerosis 22) , to metabolic conditions, such as fatty liver 23) andtype2diabetesmellitus(T2DM) 24) .Aschematic representationoftheinterplaybetweentheredoxsystem,inflammatoryprocessesanddevelopmentofatherosclerosisisprovidedinFig. 1.…”